Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Teladoc Health Inc (NYSE: TDOC) closed at $6.97 in the last session, down -1.55% from day before closing price of $7.08. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 3.66 million shares were traded.
Ratios:
We take a closer look at TDOC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.24. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.65. In the meantime, Its Debt-to-Equity ratio is 1.11 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 15, 2024, initiated with a Buy rating and assigned the stock a target price of $14.
On September 17, 2024, Jefferies reiterated its Hold rating and also lowered its target price recommendation from $8 to $10.
On February 29, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $22.Cantor Fitzgerald initiated its Overweight rating on February 29, 2024, with a $22 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 07 ’25 when Murthy Mala sold 7,494 shares for $6.81 per share. The transaction valued at 51,012 led to the insider holds 121,467 shares of the business.
Murthy Mala bought 7,494 shares of TDOC for $51,012 on Apr 07 ’25. On Mar 20 ’25, another insider, Murthy Mala, who serves as the CHIEF FINANCIAL OFFICER of the company, sold 20,586 shares for $8.42 each. As a result, the insider received 173,416 and left with 116,309 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48 while its Price-to-Book (P/B) ratio in mrq is 0.86.
Stock Price History:
Over the past 52 weeks, TDOC has reached a high of $15.21, while it has fallen to a 52-week low of $6.35. The 50-Day Moving Average of the stock is -6.20%, while the 200-Day Moving Average is calculated to be -22.11%.
Shares Statistics:
A total of 175.34M shares are outstanding, with a floating share count of 173.66M. Insiders hold about 1.01% of the company’s shares, while institutions hold 73.73% stake in the company.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 4.0 analysts currently analyzing and rating the stock of Teladoc Health Inc (TDOC).The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.17 and low estimates of -$0.28.
Analysts are recommending an EPS of between -$0.76 and -$1.44 for the fiscal current year, implying an average EPS of -$1.1. EPS for the following year is -$0.9, with 5.0 analysts recommending between -$0.7 and -$1.11.
Revenue Estimates
According to 22 analysts, the current quarter’s revenue is expected to be $622.01M. It ranges from a high estimate of $626.71M to a low estimate of $605.75M. As of the current estimate, Teladoc Health Inc’s year-ago sales were $642.44MFor the next quarter, 22 analysts are estimating revenue of $627.76M. There is a high estimate of $636.78M for the next quarter, whereas the lowest estimate is $614.61M.
A total of 23 analysts have provided revenue estimates for TDOC’s current fiscal year. The highest revenue estimate was $2.54B, while the lowest revenue estimate was $2.49B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $2.57BBased on 23 analysts’ estimates, the company’s revenue will be $2.55B in the next fiscal year. The high estimate is $2.61B and the low estimate is $2.47B.
